Cluster Headache in Subjects With Substance Use Disorder: A Case Series and a Review of the Literature
Objective To describe a case series of 7 patients presenting cluster headache (CH) criteria and a substance use disorder, reported to a French Addictovigilance center. Then, to assess clinical, pharmacological, and neurobiological linkages between substance use and CH onset. Background CH patients a...
Saved in:
| Published in: | Headache Vol. 59; no. 4; pp. 576 - 589 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
Wiley Subscription Services, Inc
01.04.2019
American Headache Society |
| Subjects: | |
| ISSN: | 0017-8748, 1526-4610, 1526-4610 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Objective
To describe a case series of 7 patients presenting cluster headache (CH) criteria and a substance use disorder, reported to a French Addictovigilance center. Then, to assess clinical, pharmacological, and neurobiological linkages between substance use and CH onset.
Background
CH patients are presenting a higher prevalence of comorbidities, among which the use of psychoactive substances, licit or illicit, have been explored by a few authors. Recently, 3 cases of CH in patients seen in the hospital‐based addiction care center have been reported to the Toulouse addictovigilance center.
Methods
Other cases have been identified in the same tertiary hospital after a collaborative investigation done with the departments of neurology and psychiatry and included in the case series. A narrative review was performed to assess the potential of psychoactive substance consumption to induce or facilitate CH.
Results
From 2016 to 2018, 6 males and 1 female aged between 26 and 54 years old, presenting CH criteria and a substance use disorder, were included in our case series. Among substances used, there are: (1) daily use of tobacco and alcohol in 5/7 subjects; (2) daily or almost daily use of cocaine in 5/7 subjects; (3) regular use of cannabis before attacks beginning in 4/7 subjects; and (4) opioids, as a substitutive medication or abused, in 5/7 subjects. The intranasal route administration is reported by all the subjects and precedes the beginning of attacks for 5/7 subjects.
Conclusions
We have found a CH prevalence of 0.9% in our studied population, while it is estimated at 0.1% in the general population. The coexistence of cluster headache and addiction behaviors reflects possible common neurobiological pathways, which would include the hypothalamus. Research could be conducted on the potential of hypothalamic therapeutic targets. |
|---|---|
| AbstractList | ObjectiveTo describe a case series of 7 patients presenting cluster headache (CH) criteria and a substance use disorder, reported to a French Addictovigilance center. Then, to assess clinical, pharmacological, and neurobiological linkages between substance use and CH onset.BackgroundCH patients are presenting a higher prevalence of comorbidities, among which the use of psychoactive substances, licit or illicit, have been explored by a few authors. Recently, 3 cases of CH in patients seen in the hospital‐based addiction care center have been reported to the Toulouse addictovigilance center.MethodsOther cases have been identified in the same tertiary hospital after a collaborative investigation done with the departments of neurology and psychiatry and included in the case series. A narrative review was performed to assess the potential of psychoactive substance consumption to induce or facilitate CH.ResultsFrom 2016 to 2018, 6 males and 1 female aged between 26 and 54 years old, presenting CH criteria and a substance use disorder, were included in our case series. Among substances used, there are: (1) daily use of tobacco and alcohol in 5/7 subjects; (2) daily or almost daily use of cocaine in 5/7 subjects; (3) regular use of cannabis before attacks beginning in 4/7 subjects; and (4) opioids, as a substitutive medication or abused, in 5/7 subjects. The intranasal route administration is reported by all the subjects and precedes the beginning of attacks for 5/7 subjects.ConclusionsWe have found a CH prevalence of 0.9% in our studied population, while it is estimated at 0.1% in the general population. The coexistence of cluster headache and addiction behaviors reflects possible common neurobiological pathways, which would include the hypothalamus. Research could be conducted on the potential of hypothalamic therapeutic targets. To describe a case series of 7 patients presenting cluster headache (CH) criteria and a substance use disorder, reported to a French Addictovigilance center. Then, to assess clinical, pharmacological, and neurobiological linkages between substance use and CH onset.OBJECTIVETo describe a case series of 7 patients presenting cluster headache (CH) criteria and a substance use disorder, reported to a French Addictovigilance center. Then, to assess clinical, pharmacological, and neurobiological linkages between substance use and CH onset.CH patients are presenting a higher prevalence of comorbidities, among which the use of psychoactive substances, licit or illicit, have been explored by a few authors. Recently, 3 cases of CH in patients seen in the hospital-based addiction care center have been reported to the Toulouse addictovigilance center.BACKGROUNDCH patients are presenting a higher prevalence of comorbidities, among which the use of psychoactive substances, licit or illicit, have been explored by a few authors. Recently, 3 cases of CH in patients seen in the hospital-based addiction care center have been reported to the Toulouse addictovigilance center.Other cases have been identified in the same tertiary hospital after a collaborative investigation done with the departments of neurology and psychiatry and included in the case series. A narrative review was performed to assess the potential of psychoactive substance consumption to induce or facilitate CH.METHODSOther cases have been identified in the same tertiary hospital after a collaborative investigation done with the departments of neurology and psychiatry and included in the case series. A narrative review was performed to assess the potential of psychoactive substance consumption to induce or facilitate CH.From 2016 to 2018, 6 males and 1 female aged between 26 and 54 years old, presenting CH criteria and a substance use disorder, were included in our case series. Among substances used, there are: (1) daily use of tobacco and alcohol in 5/7 subjects; (2) daily or almost daily use of cocaine in 5/7 subjects; (3) regular use of cannabis before attacks beginning in 4/7 subjects; and (4) opioids, as a substitutive medication or abused, in 5/7 subjects. The intranasal route administration is reported by all the subjects and precedes the beginning of attacks for 5/7 subjects.RESULTSFrom 2016 to 2018, 6 males and 1 female aged between 26 and 54 years old, presenting CH criteria and a substance use disorder, were included in our case series. Among substances used, there are: (1) daily use of tobacco and alcohol in 5/7 subjects; (2) daily or almost daily use of cocaine in 5/7 subjects; (3) regular use of cannabis before attacks beginning in 4/7 subjects; and (4) opioids, as a substitutive medication or abused, in 5/7 subjects. The intranasal route administration is reported by all the subjects and precedes the beginning of attacks for 5/7 subjects.We have found a CH prevalence of 0.9% in our studied population, while it is estimated at 0.1% in the general population. The coexistence of cluster headache and addiction behaviors reflects possible common neurobiological pathways, which would include the hypothalamus. Research could be conducted on the potential of hypothalamic therapeutic targets.CONCLUSIONSWe have found a CH prevalence of 0.9% in our studied population, while it is estimated at 0.1% in the general population. The coexistence of cluster headache and addiction behaviors reflects possible common neurobiological pathways, which would include the hypothalamus. Research could be conducted on the potential of hypothalamic therapeutic targets. Objective To describe a case series of 7 patients presenting cluster headache (CH) criteria and a substance use disorder, reported to a French Addictovigilance center. Then, to assess clinical, pharmacological, and neurobiological linkages between substance use and CH onset. Background CH patients are presenting a higher prevalence of comorbidities, among which the use of psychoactive substances, licit or illicit, have been explored by a few authors. Recently, 3 cases of CH in patients seen in the hospital‐based addiction care center have been reported to the Toulouse addictovigilance center. Methods Other cases have been identified in the same tertiary hospital after a collaborative investigation done with the departments of neurology and psychiatry and included in the case series. A narrative review was performed to assess the potential of psychoactive substance consumption to induce or facilitate CH. Results From 2016 to 2018, 6 males and 1 female aged between 26 and 54 years old, presenting CH criteria and a substance use disorder, were included in our case series. Among substances used, there are: (1) daily use of tobacco and alcohol in 5/7 subjects; (2) daily or almost daily use of cocaine in 5/7 subjects; (3) regular use of cannabis before attacks beginning in 4/7 subjects; and (4) opioids, as a substitutive medication or abused, in 5/7 subjects. The intranasal route administration is reported by all the subjects and precedes the beginning of attacks for 5/7 subjects. Conclusions We have found a CH prevalence of 0.9% in our studied population, while it is estimated at 0.1% in the general population. The coexistence of cluster headache and addiction behaviors reflects possible common neurobiological pathways, which would include the hypothalamus. Research could be conducted on the potential of hypothalamic therapeutic targets. Objective : To describe a case series of 7 patients presenting cluster headache (CH) criteria and a substance use disorder, reported to a French Addictovigilance center. Then, to assess clinical, pharmacological, and neurobiological linkages between substance use and CH onset. Background : CH patients are presenting a higher prevalence of comorbidities, among which the use of psychoactive substances, licit or illicit, have been explored by a few authors. Recently, 3 cases of CH in patients seen in the hospital-based addiction care center have been reported to the Toulouse addictovigilance center. Methods : Other cases have been identified in the same tertiary hospital after a collaborative investigation done with the departments of neurology and psychiatry and included in the case series. A narrative review was performed to assess the potential of psychoactive substance consumption to induce or facilitate CH. Result s: From 2016 to 2018, 6 males and 1 female aged between 26 and 54 years old, presenting CH criteria and a substance use disorder, were included in our case series. Among substances used, there are: (1) daily use of tobacco and alcohol in 5/7 subjects; (2) daily or almost daily use of cocaine in 5/7 subjects; (3) regular use of cannabis before attacks beginning in 4/7 subjects; and (4) opioids, as a substitutive medication or abused, in 5/7 subjects. The intranasal route administration is reported by all the subjects and precedes the beginning of attacks for 5/7 subjects. Conclusions : We have found a CH prevalence of 0.9% in our studied population, while it is estimated at 0.1% in the general population. The coexistence of cluster headache and addiction behaviors reflects possible common neurobiological pathways, which would include the hypothalamus. Research could be conducted on the potential of hypothalamic therapeutic targets. To describe a case series of 7 patients presenting cluster headache (CH) criteria and a substance use disorder, reported to a French Addictovigilance center. Then, to assess clinical, pharmacological, and neurobiological linkages between substance use and CH onset. CH patients are presenting a higher prevalence of comorbidities, among which the use of psychoactive substances, licit or illicit, have been explored by a few authors. Recently, 3 cases of CH in patients seen in the hospital-based addiction care center have been reported to the Toulouse addictovigilance center. Other cases have been identified in the same tertiary hospital after a collaborative investigation done with the departments of neurology and psychiatry and included in the case series. A narrative review was performed to assess the potential of psychoactive substance consumption to induce or facilitate CH. From 2016 to 2018, 6 males and 1 female aged between 26 and 54 years old, presenting CH criteria and a substance use disorder, were included in our case series. Among substances used, there are: (1) daily use of tobacco and alcohol in 5/7 subjects; (2) daily or almost daily use of cocaine in 5/7 subjects; (3) regular use of cannabis before attacks beginning in 4/7 subjects; and (4) opioids, as a substitutive medication or abused, in 5/7 subjects. The intranasal route administration is reported by all the subjects and precedes the beginning of attacks for 5/7 subjects. We have found a CH prevalence of 0.9% in our studied population, while it is estimated at 0.1% in the general population. The coexistence of cluster headache and addiction behaviors reflects possible common neurobiological pathways, which would include the hypothalamus. Research could be conducted on the potential of hypothalamic therapeutic targets. |
| Author | Salles, Juliette Giron, Aurélie Lapeyre‐Mestre, Maryse Fabre, Nelly Ponté, Camille Crequy, Marie |
| Author_xml | – sequence: 1 givenname: Camille orcidid: 0000-0001-8616-5313 surname: Ponté fullname: Ponté, Camille email: ponte.c@chu-toulouse.fr organization: Centre Hospitalier Universitaire de Toulouse – sequence: 2 givenname: Aurélie surname: Giron fullname: Giron, Aurélie organization: Université de Toulouse III, Centre Hospitalier Universitaire de Toulouse – sequence: 3 givenname: Marie surname: Crequy fullname: Crequy, Marie organization: Centre Hospitalier Universitaire de Toulouse – sequence: 4 givenname: Maryse surname: Lapeyre‐Mestre fullname: Lapeyre‐Mestre, Maryse organization: Centre Hospitalier Universitaire de Toulouse – sequence: 5 givenname: Nelly surname: Fabre fullname: Fabre, Nelly organization: Centre Hospitalier Universitaire de Toulouse – sequence: 6 givenname: Juliette surname: Salles fullname: Salles, Juliette organization: INSERM UMR 1043, Université de Toulouse III, Centre Hospitalier Universitaire de Toulouse |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30957220$$D View this record in MEDLINE/PubMed https://ut3-toulouseinp.hal.science/hal-03603930$$DView record in HAL |
| BookMark | eNp9kc1q3DAUhUVJaSZpN32AIuimKTiVbP3Y3Q2TNBMYKDQpXYpr-ZrR4LFTSU7I20eOkyxC6d0IHb5zhO45Igf90CMhHzk75Wm-bRGaU15Irt6QBZe5yoTi7IAsGOM6K7UoD8lRCDvGmFCVekcOC1ZJnedsQdpVN4aInq5TCNgtUtfTq7HeoY2B_nFxO91ChN4i_R2Qnrkw-Ab9d7qkK0jCFXqHgULfUKC_8NbhHR1aGlPUxqVkiKPH9-RtC13AD0_nMbn-cX69WmebnxeXq-Ums4JrlSlZg0hT18pqgLpUEluRs5bXrC0qDdzqJIIWbcuhbrBUtWy0lNZK3eTFMTmZY7fQmRvv9uDvzQDOrJcbM2msUKyoCnbLE_tlZm_88HfEEM3eBYtdBz0OYzBpPVKwShUT-vkVuhtG36ePTJTmpcxFmahPT9RY77F5ef952Qn4OgPWDyF4bF8QzszUpJmaNI9NJpi9gq2LEN3QRw-u-7eFz5Y71-H9f8LN-nx5NnseAObqrVY |
| CitedBy_id | crossref_primary_10_3390_jcm14186475 crossref_primary_10_1007_s42399_023_01423_1 crossref_primary_10_1111_head_14831 crossref_primary_10_1177_03331024231201577 crossref_primary_10_1007_s11916_022_01063_5 crossref_primary_10_1016_j_ncl_2022_02_005 crossref_primary_10_1155_ane_5587883 crossref_primary_10_1097_ADT_0000000000000266 crossref_primary_10_1111_head_14364 crossref_primary_10_1007_s40278_019_62484_7 crossref_primary_10_7759_cureus_10128 |
| Cites_doi | 10.1016/j.neuron.2012.03.017 10.1177/0333102412458188 10.1007/s00406-017-0809-7 10.1007/s10194-010-0217-0 10.1186/s12954-017-0186-6 10.1007/s11916-014-0413-8 10.1080/02791072.2015.1107664 10.1186/1129-2377-14-S1-P54 10.1046/j.1468-2982.1993.1305309.x 10.1212/WNL.54.1.219 10.1007/s11916-002-0026-5 10.1186/1129-2377-15-S1-C46 10.1111/head.12213 10.1111/j.1369-1600.2010.00247.x 10.1177/0333102417738202 10.4103/0976-3147.178654 10.1177/0333102412468669 10.1177/0269881115622240 10.1111/j.1526-4610.1994.hed3403143.x 10.1111/j.1468-2982.2008.01592.x 10.1111/j.1468-2982.2007.01330.x 10.1038/nrdp.2018.6 10.1111/head.13338 10.1038/sj.bjp.0706789 10.1016/bs.pbr.2017.08.005 10.1007/7854_2016_55 10.1111/head.12621 10.2515/therapie/2014211 10.1067/moe.2000.107834 10.1016/j.amepre.2015.05.027 10.1111/j.1526-4610.2009.01542.x 10.1111/j.1526-4610.2009.01344.x 10.1046/j.1468-2982.2002.00432.x 10.1111/j.1526-4610.2007.00842.x 10.1111/head.13135 10.1111/head.13295 10.1111/head.12068 10.1177/0333102412458190 10.1177/0333102415583145 10.1186/s10194-017-0785-3 10.1080/14737175.2016.1216796 10.1186/s13049-017-0369-x 10.1016/j.therap.2016.07.001 10.1002/lary.27240 10.1016/j.neuropharm.2004.06.032 10.1212/01.wnl.0000219761.05466.43 10.1016/j.brainres.2009.09.106 10.1177/0333102410363490 10.2174/1570159X13666150309233556 10.1111/pme.12101 10.1186/1129-2377-14-48 10.1016/S1474-4422(02)00104-7 10.1007/s10072-013-1540-4 10.1046/j.1468-2982.1999.019002088.x 10.1212/WNL.0b013e31822313c6 10.1038/nn.4220 10.1111/j.1526-4610.2006.00534.x 10.1016/j.neurol.2014.03.016 |
| ContentType | Journal Article |
| Copyright | 2019 American Headache Society 2019 American Headache Society. Distributed under a Creative Commons Attribution 4.0 International License |
| Copyright_xml | – notice: 2019 American Headache Society – notice: 2019 American Headache Society. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
| DBID | AAYXX CITATION NPM 7TK 7U7 C1K K9. 7X8 1XC |
| DOI | 10.1111/head.13516 |
| DatabaseName | CrossRef PubMed Neurosciences Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic Hyper Article en Ligne (HAL) |
| DatabaseTitle | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) Toxicology Abstracts Neurosciences Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1526-4610 |
| EndPage | 589 |
| ExternalDocumentID | oai:HAL:hal-03603930v1 30957220 10_1111_head_13516 HEAD13516 |
| Genre | article Journal Article |
| GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 29I 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5RE 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AAQQT AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIVO ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AI. AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS ECV EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FYBCS G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO L7B LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 VH1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQ9 WQJ WRC WVDHM WXI WXSBR XG1 YCJ YFH YUY ZGI ZXP ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE CITATION O8X NPM PKN 7TK 7U7 C1K K9. 7X8 1XC |
| ID | FETCH-LOGICAL-c4176-65ba4444bb6c7aab865ef420f1b0f397a1c7b86a74ff1abde86b5d755cc57d23 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 9 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000465079700010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0017-8748 1526-4610 |
| IngestDate | Sat Nov 29 15:05:19 EST 2025 Wed Oct 01 14:59:18 EDT 2025 Fri Oct 03 03:30:40 EDT 2025 Wed Feb 19 02:31:59 EST 2025 Tue Nov 18 22:23:50 EST 2025 Sat Nov 29 06:58:39 EST 2025 Wed Jan 22 16:25:03 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | comorbidity addictovigilance drugs cluster headache |
| Language | English |
| License | 2019 American Headache Society. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4176-65ba4444bb6c7aab865ef420f1b0f397a1c7b86a74ff1abde86b5d755cc57d23 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Case Study-2 ObjectType-Review-5 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
| ORCID | 0000-0001-8616-5313 0000-0002-4497-8006 |
| PMID | 30957220 |
| PQID | 2207185248 |
| PQPubID | 24968 |
| PageCount | 14 |
| ParticipantIDs | hal_primary_oai_HAL_hal_03603930v1 proquest_miscellaneous_2205409631 proquest_journals_2207185248 pubmed_primary_30957220 crossref_primary_10_1111_head_13516 crossref_citationtrail_10_1111_head_13516 wiley_primary_10_1111_head_13516_HEAD13516 |
| PublicationCentury | 2000 |
| PublicationDate | April 2019 |
| PublicationDateYYYYMMDD | 2019-04-01 |
| PublicationDate_xml | – month: 04 year: 2019 text: April 2019 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Mt. Royal |
| PublicationTitle | Headache |
| PublicationTitleAlternate | Headache |
| PublicationYear | 2019 |
| Publisher | Wiley Subscription Services, Inc American Headache Society |
| Publisher_xml | – name: Wiley Subscription Services, Inc – name: American Headache Society |
| References | 2010; 11 2010; 15 2015; 70 2016; 30 2000; 90 2016; 71 2014; 170 2017; 235 2009; 49 2016; 36 2015; 47 2013; 14 2018; 4 2000; 15 1999; 19 2006; 66 2000; 54 2017; 33 2013; 53 2008; 28 1994; 34 2014; 15 2014; 18 2018; 38 2010; 30 2007; 27 2015; 13 2016; 19 2017; 25 2004; 47 2002; 6 2015; 55 2002; 7 2018; 268 2002; 1 2011; 77 2016; 50 2003 2012; 32 2012; 74 2010; 1314 1993; 13 2016; 7 2013; 33 2006; 46 2017; 14 2017; 17 2017; 57 2002; 22 2017; 12 2014; 35 2017; 18 2014 2006; 148 2007; 47 2010; 50 2018; 58 Massiou H (e_1_2_9_29_1) 2003 e_1_2_9_31_1 e_1_2_9_52_1 e_1_2_9_50_1 e_1_2_9_10_1 e_1_2_9_35_1 e_1_2_9_56_1 e_1_2_9_12_1 e_1_2_9_33_1 e_1_2_9_54_1 e_1_2_9_14_1 e_1_2_9_16_1 e_1_2_9_37_1 e_1_2_9_58_1 e_1_2_9_18_1 e_1_2_9_41_1 e_1_2_9_64_1 Italian Cooperative Study Group on the Epidemiology of Cluster Headache (ICECH) (e_1_2_9_17_1) 2000; 15 e_1_2_9_62_1 e_1_2_9_22_1 e_1_2_9_45_1 e_1_2_9_43_1 e_1_2_9_8_1 e_1_2_9_6_1 e_1_2_9_4_1 e_1_2_9_60_1 e_1_2_9_2_1 Pasquereau A (e_1_2_9_24_1) 2017; 12 e_1_2_9_26_1 e_1_2_9_49_1 e_1_2_9_28_1 e_1_2_9_47_1 Rey JMG (e_1_2_9_39_1) 2002; 7 e_1_2_9_30_1 e_1_2_9_53_1 e_1_2_9_51_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_57_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_55_1 SAMHSA (Substance Abuse and Mental Health Services Administration) (e_1_2_9_20_1) 2014 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_36_1 e_1_2_9_59_1 e_1_2_9_19_1 e_1_2_9_42_1 e_1_2_9_63_1 e_1_2_9_40_1 e_1_2_9_61_1 e_1_2_9_21_1 e_1_2_9_46_1 e_1_2_9_23_1 e_1_2_9_44_1 e_1_2_9_7_1 e_1_2_9_5_1 e_1_2_9_3_1 e_1_2_9_9_1 e_1_2_9_25_1 e_1_2_9_27_1 e_1_2_9_48_1 |
| References_xml | – volume: 11 start-page: 289 year: 2010 end-page: 299 article-title: Prevalence of headache in Europe: A review for the Eurolight project publication-title: J Headache Pain – volume: 50 start-page: 1 year: 2016 end-page: 8 article-title: Toking, vaping, and eating for health or fun: Marijuana use patterns in adults, U.S., 2014 publication-title: Am J Prev Med – volume: 28 start-page: 614 year: 2008 end-page: 618 article-title: The incidence and prevalence of cluster headache: A meta‐analysis of population‐based studies publication-title: Cephalalgia – article-title: Linking cigarette smoking/tobacco exposure and cluster headache: A pathogenesis theory publication-title: Headache – volume: 47 start-page: 951 year: 2007 end-page: 962 article-title: The hypothalamic orexinergic system: Pain and primary headaches publication-title: Headache – volume: 46 start-page: 1246 year: 2006 end-page: 1254 article-title: Cluster headache: Clinical presentation, lifestyle features, and medical treatment publication-title: Headache – article-title: Velopharyngeal dysfunction from intranasal substance abuse: Case series and review of literature publication-title: Laryngoscope – volume: 36 start-page: 194 year: 2016 end-page: 198 article-title: The use of illicit drugs as self‐medication in the treatment of cluster headache: Results from an Italian online survey publication-title: Cephalalgia – year: 2014 – volume: 19 start-page: 88 year: 1999 end-page: 94 article-title: Cluster headache and lifestyle: Remarks on a population of 374 male patients publication-title: Cephalalgia – volume: 33 start-page: 221 year: 2017 end-page: 246 article-title: The role of orexins/hypocretins in alcohol use and abuse publication-title: Curr Top Behav Neurosci – year: 2003 article-title: Algie vasculaire de la face. Encycl Méd Chir (Editions Scientifiques et Médicales Elsevier SAS, Paris) publication-title: Neurologie – volume: 53 start-page: 1470 year: 2013 end-page: 1478 article-title: Diagnosis and clinical features of trigemino‐autonomic headaches publication-title: Headache – volume: 14 start-page: 802 year: 2013 end-page: 807 article-title: Clinical features of cluster headache: An outpatient clinic study from China publication-title: Pain Med – volume: 53 start-page: 1490 year: 2013 end-page: 1491 article-title: Efficiency of sodium oxybate in episodic cluster headache publication-title: Headache – volume: 1 start-page: 251 year: 2002 end-page: 257 article-title: Pathophysiology of cluster headache: A trigeminal autonomic cephalgia publication-title: Lancet Neurol – volume: 7 start-page: 269 year: 2016 end-page: 275 article-title: Alcohol‐induced headaches: Evidence for a central mechanism? publication-title: J Neurosci Rural Pract – volume: 15 start-page: 215 year: 2000 end-page: 223 article-title: Case‐control study on the epidemiology of cluster headache. II: Anthropometric data and personality profile publication-title: Funct Neurol – volume: 35 start-page: 319 year: 2014 end-page: 321 article-title: Cocaine‐induced cluster‐like headache publication-title: Neurol Sci – volume: 13 start-page: 304 year: 2015 end-page: 323 article-title: The neuropharmacology of cluster headache and other trigeminal autonomic cephalalgias publication-title: Curr Neuropharmacol – volume: 13 start-page: 309 year: 1993 end-page: 317 article-title: A review of hormonal findings in cluster headache. Evidence for hypothalamic involvement publication-title: Cephalalgia – volume: 14 start-page: 48 year: 2013 article-title: Impact of continuing or quitting smoking on episodic cluster headache: A pilot survey publication-title: J Headache Pain – volume: 268 start-page: 243 year: 2018 end-page: 248 article-title: Total hypothalamic volume is reduced in postmortem brains of male heroin addicts publication-title: Eur Arch Psychiatry Clin Neurosci – volume: 74 start-page: 858 year: 2012 end-page: 873 article-title: Whole‐brain mapping of direct inputs to midbrain dopamine neurons publication-title: Neuron – volume: 170 start-page: 653 year: 2014 end-page: 670 article-title: French guidelines for diagnosis and treatment of cluster headache (French Headache Society) publication-title: Rev Neurol – volume: 12 start-page: 214 year: 2017 end-page: 222 article-title: Tobacco and e‐cigarette in France: Levels of consumption according the preliminary results from 2016 Health Barometer publication-title: Bull Epidémiologique Hebd – volume: 50 start-page: 130 year: 2010 end-page: 132 article-title: Cluster headache as the result of secondhand cigarette smoke exposure during childhood publication-title: Headache – volume: 22 start-page: 725 year: 2002 end-page: 729 article-title: Atypical presentations of cluster headache publication-title: Cephalalgia – volume: 77 start-page: 67 year: 2011 end-page: 70 article-title: Long‐term efficacy of sodium oxybate in 4 patients with chronic cluster headache publication-title: Neurology – volume: 33 start-page: 208 year: 2013 end-page: 213 article-title: Use of cannabis among 139 cluster headache sufferers publication-title: Cephalalgia – volume: 30 start-page: 1140 year: 2010 end-page: 1144 article-title: The non‐hallucinogen 2‐bromo‐lysergic acid diethylamide as preventative treatment for cluster headache: An open, non‐randomized case series publication-title: Cephalalgia – volume: 17 start-page: 165 year: 2017 end-page: 172 article-title: Advances in the understanding of cluster headache publication-title: Expert Rev Neurother – volume: 47 start-page: 227 year: 2004 end-page: 241 article-title: Dopamine and drug addiction: The nucleus accumbens shell connection publication-title: Neuropharmacology – volume: 18 start-page: 413 year: 2014 article-title: Licit and illicit drug use in cluster headache publication-title: Curr Pain Headache Rep – volume: 25 start-page: 26 year: 2017 article-title: Presentations to an urban emergency department in Bern, Switzerland associated with acute recreational drug toxicity publication-title: Scand J Trauma Resusc Emerg Med – volume: 55 start-page: 1045 year: 2015 end-page: 1049 article-title: Headache and alcohol publication-title: Headache – volume: 27 start-page: 535 year: 2007 end-page: 541 article-title: Burden of cluster headache publication-title: Cephalalgia – volume: 32 start-page: 1021 year: 2012 end-page: 1022 article-title: Illicit drugs and cluster headache: An inevitable discussion publication-title: Cephalalgia – volume: 71 start-page: 563 year: 2016 end-page: 573 article-title: Medical complications of psychoactive substances with abuse risks: Detection and assessment by the network of French addictovigilance centres publication-title: Therapie – volume: 49 start-page: 914 year: 2009 end-page: 916 article-title: Cluster attacks responsive to recreational cannabis and dronabinol publication-title: Headache – volume: 54 start-page: 219 year: 2000 end-page: 221 article-title: Cluster headache with aura publication-title: Neurology – volume: 32 start-page: 1031 year: 2012 end-page: 1040 article-title: Illicit drug use in cluster headache patients and in the general population: A comparative cross‐sectional survey publication-title: Cephalalgia – volume: 4 start-page: 18006 year: 2018 article-title: Cluster headache publication-title: Nat Rev Dis Primer – volume: 15 start-page: 448 year: 2010 end-page: 463 article-title: Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus publication-title: Addict Biol – volume: 58 start-page: 688 year: 2018 end-page: 699 article-title: Cluster headache clinical phenotypes: Tobacco nonexposed (never smoker and no parental secondary smoke exposure as a child) versus tobacco‐exposed: Results from the United States Cluster Headache Survey publication-title: Headache – volume: 1314 start-page: 74 year: 2010 end-page: 90 article-title: Lateral hypothalamic orexin/hypocretin neurons: A role in reward‐seeking and addiction publication-title: Brain Res – volume: 14 start-page: 60 year: 2017 article-title: Psychoactive substances as a last resort‐a qualitative study of self–treatment of migraine and cluster headaches publication-title: Harm Reduct J – volume: 57 start-page: 1261 year: 2017 end-page: 1264 article-title: Ketamine infusion combined with magnesium as a therapy for intractable chronic cluster headache: Report of two cases publication-title: Headache – volume: 148 start-page: 752 year: 2006 end-page: 759 article-title: The orexin system regulates alcohol‐seeking in rats publication-title: Br J Pharmacol – volume: 18 start-page: 76 year: 2017 article-title: The comorbidity burden of patients with cluster headache: A population‐based study publication-title: J Headache Pain – volume: 90 start-page: 271 year: 2000 end-page: 274 article-title: Cluster headache and cocaine use publication-title: Oral Surg Oral Med Oral Pathol Oral Radiol Endod – volume: 19 start-page: 198 year: 2016 end-page: 205 article-title: Lateral hypothalamic circuits for feeding and reward publication-title: Nat Neurosci – volume: 14 start-page: P54 year: 2013 article-title: Can cigarette smoking worsen the clinical course of cluster headache? publication-title: J Headache Pain – volume: 7 start-page: 103 year: 2002 end-page: 107 article-title: Lesiones inducidas por la aplicación tópica de cocaína publication-title: Med Oral – volume: 70 start-page: 305 year: 2015 end-page: 307 article-title: Role of methadone in induction and/or exacerbation of cluster headache in patients treated for opioid addiction publication-title: Therapie – volume: 30 start-page: 112 year: 2016 end-page: 127 article-title: Neurotensin: A role in substance use disorder? publication-title: J Psychopharmacol Oxf Engl – volume: 34 start-page: 143 year: 1994 end-page: 147 article-title: Does quality of life differ among headache diagnoses? Analysis using the medical outcomes study instrument publication-title: Headache – volume: 66 start-page: 1920 year: 2006 end-page: 1922 article-title: Response of cluster headache to psilocybin and LSD publication-title: Neurology – volume: 38 start-page: 1 year: 2018 end-page: 211 article-title: The International Classification of Headache Disorders publication-title: Cephalalgia – volume: 6 start-page: 65 year: 2002 end-page: 70 article-title: What predicts evolution from episodic to chronic cluster headache? publication-title: Curr Pain Headache Rep – volume: 15 start-page: C46 year: 2014 article-title: EHMTI‐0136. Medical cannabis in the treatment of treatment‐resistant, chronic cluster headache. A retrospective report publication-title: J Headache Pain – volume: 235 start-page: 139 year: 2017 end-page: 154 article-title: Functional roles of orexin/hypocretin receptors in reward circuit publication-title: Prog Brain Res – volume: 47 start-page: 372 year: 2015 end-page: 381 article-title: Indoleamine hallucinogens in cluster headache: Results of the clusterbusters medication use survey publication-title: J Psychoactive Drugs – ident: e_1_2_9_51_1 doi: 10.1016/j.neuron.2012.03.017 – ident: e_1_2_9_16_1 doi: 10.1177/0333102412458188 – year: 2003 ident: e_1_2_9_29_1 article-title: Algie vasculaire de la face. Encycl Méd Chir (Editions Scientifiques et Médicales Elsevier SAS, Paris) publication-title: Neurologie – ident: e_1_2_9_53_1 doi: 10.1007/s00406-017-0809-7 – ident: e_1_2_9_4_1 doi: 10.1007/s10194-010-0217-0 – ident: e_1_2_9_36_1 doi: 10.1186/s12954-017-0186-6 – ident: e_1_2_9_15_1 doi: 10.1007/s11916-014-0413-8 – ident: e_1_2_9_44_1 doi: 10.1080/02791072.2015.1107664 – ident: e_1_2_9_27_1 doi: 10.1186/1129-2377-14-S1-P54 – ident: e_1_2_9_62_1 doi: 10.1046/j.1468-2982.1993.1305309.x – ident: e_1_2_9_11_1 doi: 10.1212/WNL.54.1.219 – ident: e_1_2_9_30_1 doi: 10.1007/s11916-002-0026-5 – ident: e_1_2_9_34_1 doi: 10.1186/1129-2377-15-S1-C46 – ident: e_1_2_9_5_1 doi: 10.1111/head.12213 – ident: e_1_2_9_52_1 doi: 10.1111/j.1369-1600.2010.00247.x – ident: e_1_2_9_8_1 doi: 10.1177/0333102417738202 – ident: e_1_2_9_32_1 doi: 10.4103/0976-3147.178654 – ident: e_1_2_9_33_1 doi: 10.1177/0333102412468669 – ident: e_1_2_9_57_1 doi: 10.1177/0269881115622240 – ident: e_1_2_9_13_1 doi: 10.1111/j.1526-4610.1994.hed3403143.x – ident: e_1_2_9_6_1 doi: 10.1111/j.1468-2982.2008.01592.x – ident: e_1_2_9_12_1 doi: 10.1111/j.1468-2982.2007.01330.x – ident: e_1_2_9_9_1 doi: 10.1038/nrdp.2018.6 – ident: e_1_2_9_19_1 doi: 10.1111/head.13338 – ident: e_1_2_9_55_1 doi: 10.1038/sj.bjp.0706789 – ident: e_1_2_9_64_1 doi: 10.1016/bs.pbr.2017.08.005 – ident: e_1_2_9_56_1 doi: 10.1007/7854_2016_55 – ident: e_1_2_9_31_1 doi: 10.1111/head.12621 – ident: e_1_2_9_42_1 doi: 10.2515/therapie/2014211 – ident: e_1_2_9_40_1 doi: 10.1067/moe.2000.107834 – ident: e_1_2_9_37_1 doi: 10.1016/j.amepre.2015.05.027 – ident: e_1_2_9_25_1 doi: 10.1111/j.1526-4610.2009.01542.x – ident: e_1_2_9_35_1 doi: 10.1111/j.1526-4610.2009.01344.x – ident: e_1_2_9_10_1 doi: 10.1046/j.1468-2982.2002.00432.x – ident: e_1_2_9_61_1 doi: 10.1111/j.1526-4610.2007.00842.x – ident: e_1_2_9_46_1 doi: 10.1111/head.13135 – ident: e_1_2_9_28_1 doi: 10.1111/head.13295 – ident: e_1_2_9_47_1 doi: 10.1111/head.12068 – ident: e_1_2_9_18_1 doi: 10.1177/0333102412458190 – ident: e_1_2_9_38_1 doi: 10.1177/0333102415583145 – ident: e_1_2_9_14_1 doi: 10.1186/s10194-017-0785-3 – ident: e_1_2_9_60_1 doi: 10.1080/14737175.2016.1216796 – volume: 12 start-page: 214 year: 2017 ident: e_1_2_9_24_1 article-title: Tobacco and e‐cigarette in France: Levels of consumption according the preliminary results from 2016 Health Barometer publication-title: Bull Epidémiologique Hebd – ident: e_1_2_9_3_1 doi: 10.1186/s13049-017-0369-x – volume-title: Age‐ and Gender‐Based Populations year: 2014 ident: e_1_2_9_20_1 – ident: e_1_2_9_2_1 doi: 10.1016/j.therap.2016.07.001 – ident: e_1_2_9_49_1 doi: 10.1002/lary.27240 – ident: e_1_2_9_50_1 doi: 10.1016/j.neuropharm.2004.06.032 – ident: e_1_2_9_45_1 doi: 10.1212/01.wnl.0000219761.05466.43 – ident: e_1_2_9_54_1 doi: 10.1016/j.brainres.2009.09.106 – ident: e_1_2_9_43_1 doi: 10.1177/0333102410363490 – ident: e_1_2_9_59_1 doi: 10.2174/1570159X13666150309233556 – ident: e_1_2_9_23_1 doi: 10.1111/pme.12101 – ident: e_1_2_9_26_1 doi: 10.1186/1129-2377-14-48 – volume: 15 start-page: 215 year: 2000 ident: e_1_2_9_17_1 article-title: Case‐control study on the epidemiology of cluster headache. II: Anthropometric data and personality profile publication-title: Funct Neurol – volume: 7 start-page: 103 year: 2002 ident: e_1_2_9_39_1 article-title: Lesiones inducidas por la aplicación tópica de cocaína publication-title: Med Oral – ident: e_1_2_9_58_1 doi: 10.1016/S1474-4422(02)00104-7 – ident: e_1_2_9_41_1 doi: 10.1007/s10072-013-1540-4 – ident: e_1_2_9_22_1 doi: 10.1046/j.1468-2982.1999.019002088.x – ident: e_1_2_9_48_1 doi: 10.1212/WNL.0b013e31822313c6 – ident: e_1_2_9_63_1 doi: 10.1038/nn.4220 – ident: e_1_2_9_21_1 doi: 10.1111/j.1526-4610.2006.00534.x – ident: e_1_2_9_7_1 doi: 10.1016/j.neurol.2014.03.016 |
| SSID | ssj0004696 |
| Score | 2.3047807 |
| SecondaryResourceType | review_article |
| Snippet | Objective
To describe a case series of 7 patients presenting cluster headache (CH) criteria and a substance use disorder, reported to a French Addictovigilance... To describe a case series of 7 patients presenting cluster headache (CH) criteria and a substance use disorder, reported to a French Addictovigilance center.... ObjectiveTo describe a case series of 7 patients presenting cluster headache (CH) criteria and a substance use disorder, reported to a French Addictovigilance... Objective : To describe a case series of 7 patients presenting cluster headache (CH) criteria and a substance use disorder, reported to a French... |
| SourceID | hal proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 576 |
| SubjectTerms | Addictions addictovigilance Adult Alcoholic beverages Cannabis cluster headache Cluster Headache / epidemiology Clusters Cocaine Coexistence Comorbidity Drug abuse drugs Female France / epidemiology Headache Headaches Human health and pathology Humans Hypothalamus Infectious diseases Life Sciences Literature reviews Male Males Middle Aged Narcotics Neurobiology Neurology Opioids Patients Pharmacology Population studies Psychiatry Substance use Substance use disorder Substance-Related Disorders / epidemiology Therapeutic applications Tobacco |
| Title | Cluster Headache in Subjects With Substance Use Disorder: A Case Series and a Review of the Literature |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fhead.13516 https://www.ncbi.nlm.nih.gov/pubmed/30957220 https://www.proquest.com/docview/2207185248 https://www.proquest.com/docview/2205409631 https://ut3-toulouseinp.hal.science/hal-03603930 |
| Volume | 59 |
| WOSCitedRecordID | wos000465079700010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1526-4610 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0004696 issn: 0017-8748 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Za9tAEB5ip5S-pHfjNA3T46UFgSRrtbulL8aJ8YMbSkmo38TuakUMQS6Rnd-fGV1NaAiUvukYaYXm-vb6BuCTTpWwFOeCPDQ6SKgDEGih8yCyofVK55Tl87rYhDw9Vcul_rED37q9MA0_RD_gxp5Rx2t2cGOrW07ONey5akOUDmA3JsMVQ9g9_jk7X9zaF1nX52oisUxUS0_KK3n-PH0nIQ0ueDnk31jzLnStc8_s6f999TPYazEnThojeQ47vnwBj7-3s-ovoZhebpkvAef0GBM846pEiig8RFPhr9Xmgs8YRjqP55XHjrLzK05wSmkQeYzNV2jKHA020w24LpDAJS563uZXcDY7OZvOg7b-QuCSSKZBKqwh7SXWpk4aY1UqfJHEYUGKLAjHmMhJumhkUhSRsblXqRW5FMI5IfN4_BqG5br0-4DKKTm2kdaOyXD4wMixLwgLJiJ0OhrB504HmWu5yblExmXW9VH4v2X1fxvBx172d8PIca_UB1JlL8Ak2vPJIuNrlLN5Q3J4Tc0edprOWtetsjgm1KVEnKgRvO9vk9PxTIop_XpbyxDSpdhFr3jTWEjf1JhAqySBEXypDeGBj8zmJ5Pj-ujgX4TfwhOCbbpZP3QIw83V1r-DR-56s6qujmAgl-qodYUbCYsHCw |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ba9swFD70Mra9rLu22dpNu7xsYLAdyZL2FtIGl7phjJT1zUiyTAPFGXXS379zbMdr2SiUvtnykW18bp91-Q7AF50oYTHOBUVodMDxByDQQhdBZEPrlS4wyxdNsQk5narzc_2jW5tDe2Fafoh-wI08o4nX5OA0IH3Dy6mIPZVtiJJN2OZoR2jg24c_J2fZjY2RTYGuNhRLrjp-UlrK87f3rYy0eUHrIf8Fm7exa5N8JjsPfO3n8KxDnWzUmskL2PDVS3h82s2rv4JyfLkixgSWYjeieGbzimFMoUGamv2aLy_ojICk8-ys9mxN2vmdjdgYEyGjUTZfM1MVzLB2woEtSobwkmU9c_NrmE2OZuM06CowBI5HMgkSYQ3qj1ubOGmMVYnwJY_DElVZIpIxkZPYaCQvy8jYwqvEikIK4ZyQRTx8A1vVovJ7wJRTcmgjrR3R4dCBkUNfIhrkInQ6GsDXtRJy17GTU5GMy3z9l0LfLW--2wA-97K_W06O_0p9Ql32AkSjnY6ynNowa9OW5PAaH7u_VnXeOW-dxzHiLiVirgbwsb-MbkdzKabyi1Ujg1gXoxfeYrc1kf5RQ4StEgUG8K2xhDteMk-PRofN0dv7CH-AJ-nsNMuz4-nJO3iKIE63q4n2YWt5tfIH8MhdL-f11fvOI_4Am0IKEw |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9tAEB4ap4Rekr7rNm23j0sDAknWandzM3aMS10TSkJzE_skhiCHyM7vz4wkqwkpgdKbHiNp2dmZ-bQ7-w3AV5VLbtDPRS7WKsrwByBSXLkoMbHxUjmM8q4uNiHmc3l2po7b3BzaC9PwQ3QTbmQZtb8mA_eXLtyycipiT2UbknwLtjOqItOD7fGvyens1sbIukBX44pFJlt-Ukrl-fP0nYi0dU75kPfB5l3sWgefyd5_Nvsp7Laokw2bYfIMHvnyOez8bNfVX0AYXayJMYFN8TGieGaLkqFPoUmaiv1erM7pjICk9ey08mxD2nnIhmyEgZDRLJuvmC4d06xZcGDLwBBeslnH3PwSTiZHJ6Np1FZgiGyWiDzKudGov8yY3Aqtjcy5D1kaB1RlQCSjEyvwohZZCIk2zsvccCc4t5YLlw5eQa9clv4NMGmlGJhEKUt0OHSgxcAHRIMZj61K-vBto4TCtuzkVCTjotj8pVC_FXW_9eFLJ3vZcHL8Veoz6rITIBrt6XBW0DWM2rQlOb7Gz-5vVF20xlsVaYq4S_I0k3341N1Gs6O1FF365bqWQayL3gtf8boZIt2nBghbBQr04aAeCQ80spgeDcf10dt_Ef4IO8fjSTH7Pv_xDp4ghlNNMtE-9FZXa_8eHtvr1aK6-tAaxA0WVgmO |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cluster+Headache+in+Subjects+With+Substance+Use+Disorder%3A+A+Case+Series+and+a+Review+of+the+Literature&rft.jtitle=Headache&rft.au=Pont%C3%A9%2C+Camille&rft.au=Giron%2C+Aur%C3%A9lie&rft.au=Crequy%2C+Marie&rft.au=Maryse+Lapeyre%E2%80%90Mestre&rft.date=2019-04-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0017-8748&rft.eissn=1526-4610&rft.volume=59&rft.issue=4&rft.spage=576&rft.epage=589&rft_id=info:doi/10.1111%2Fhead.13516&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0017-8748&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0017-8748&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0017-8748&client=summon |